MEDIFAST (MED)
(Delayed Data from NYSE)
$18.30 USD
-0.30 (-1.61%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $18.31 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Balance Sheet
Fiscal Year End for MEDIFAST INC falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 150 | 88 | 110 | 174 | 93 |
Receivables | 0 | 0 | 0 | 1 | 1 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 55 | 119 | 180 | 53 | 49 |
Other Current Assets | 19 | 16 | 17 | 6 | 11 |
Total Current Assets | 224 | 223 | 307 | 234 | 154 |
Net Property & Equipment | 51 | 57 | 56 | 28 | 26 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 4 | 5 | 4 | 1 | 1 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 15 | 12 | 6 | 3 | 0 |
Total Assets | 310 | 316 | 398 | 276 | 195 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 86 | 135 | 163 | 108 | 76 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 92 | 141 | 170 | 111 | 79 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 108 | 161 | 196 | 119 | 90 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 27 | 22 | 12 | 8 | 0 |
Retained Earnings | 175 | 140 | 190 | 154 | 169 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 6 | 0 | 5 | 64 |
Total Shareholder's Equity | 201 | 155 | 202 | 157 | 105 |
Total Liabilities & Shareholder's Equity | 310 | 316 | 398 | 276 | 195 |
Total Common Equity | 201 | 155 | 202 | 157 | 105 |
Shares Outstanding | 10.80 | 10.90 | 11.60 | 11.70 | 11.60 |
Book Value Per Share | 18.66 | 14.22 | 17.45 | 13.44 | 9.04 |
Fiscal Year End for MEDIFAST INC falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 164 | 156 | 150 | 158 | 147 |
Receivables | 0 | 0 | 0 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 40 | 46 | 55 | 58 | 69 |
Other Current Assets | 21 | 17 | 19 | 8 | 13 |
Total Current Assets | 224 | 220 | 224 | 224 | 229 |
Net Property & Equipment | 40 | 51 | 51 | 53 | 54 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 4 | 4 | 4 | 11 | 5 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 12 | 14 | 15 | 16 | 14 |
Total Assets | 294 | 303 | 310 | 320 | 319 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 69 | 71 | 86 | 103 | 105 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 1 | 4 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 75 | 77 | 92 | 110 | 115 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 17 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 88 | 92 | 108 | 127 | 133 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 30 | 28 | 27 | 24 | 22 |
Retained Earnings | 175 | 183 | 175 | 169 | 164 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 205 | 211 | 201 | 193 | 186 |
Total Liabilities & Shareholder's Equity | 294 | 303 | 310 | 320 | 319 |
Total Common Equity | 205 | 211 | 201 | 193 | 186 |
Shares Outstanding | 10.90 | 10.90 | 10.80 | 10.80 | 10.80 |
Book Value Per Share | 18.83 | 19.35 | 18.66 | 17.87 | 17.18 |